Integra Lifesciences Holdings Corp (NAS:IART)
$ 24.8 -0.73 (-2.86%) Market Cap: 1.91 Bil Enterprise Value: 3.63 Bil PE Ratio: 0 PB Ratio: 1.26 GF Score: 72/100

Q1 2022 Integra Lifesciences Holdings Corp Earnings Call Transcript

Apr 27, 2022 / 12:30PM GMT
Release Date Price: $62.09 (+2.44%)
Operator

Good day, and welcome to the Integra LifeSciences' First Quarter 2022 Financial Results. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr. Chris Ward, Senior Director, Investor Relations. Please go ahead, sir.

Chris Ward

Thank you, Cecilia. Good morning, and thank you for joining the Integra LifeSciences' First Quarter 2022 Earnings Conference Call. Joining me on the call this morning are Jan De Witte, President and Chief Executive Officer; Glenn Coleman, Chief Operating Officer; and Carrie Anderson, Chief Financial Officer.

Earlier today, we issued a press release announcing our first quarter 2022 financial results. The release and corresponding earnings presentation, which we will reference during the call, are available at integralife.com under Investors, Events and Presentations in the file named First Quarter 2022 Earnings Call Presentation.

Before we begin, I would like to remind you that many of the statements made during this call may be considered forward-looking statements. Factors that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot